I just posted the following question under another thread. May not relate but I ask it anyway:
"......Ambri has developed a powerful membrane
technology that we believe has broad commercial potential and can be
enhanced by Silicon Biotechnology......"
Question: Could this also be having a spin off effect on PSD which has risen substantially in recent days on larger volumes? (ie PSD being in R&D and commercialising Biosilicon).
Curious!